PeptidePedia The community reference

Contributions of BUD_Bertram

User contributions·28 logged edits·page 1 of 1

Contributions by BUD_Bertram, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,922 edits includes activity predating the current log.

  1. 09:48, 14 Jul 2026 (diff | hist) Talk:Beyond-use date 1,792 +157 /* Community dating practice: describe or omit? */ reply
  2. 23:35, 27 Apr 2026 (diff | hist) Dulaglutide 5,490 ±0 fix the amino-acid substitution — position 8, not position 2
  3. 09:00, 26 Apr 2026 (diff | hist) Subcutaneous injection 5,293 ±0 add the shelf life after first puncture, attributed
  4. 05:20, 16 Mar 2026 (diff | hist) Beyond-use date 23,171 ±0 m state the syringe graduation the unit figure assumes
  5. 05:03, 26 Feb 2026 (diff | hist) Reconstitution of lyophilised peptides 5,761 ±0 add a second worked example at a different vial strength
  6. 12:31, 2 Feb 2026 (diff | hist) Talk:Beyond-use date 611 +369 /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
  7. 01:04, 10 Jan 2026 (diff | hist) Bacteriostatic water 4,652 ±0 m clarify that the figure is per dose, not per vial
  8. 15:08, 8 Jan 2026 (diff | hist) Multi-dose vial 23,705 ±0 m close an unbalanced quotation mark
  9. 14:30, 26 Nov 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 5,791 ±0 m add the placebo rate next to the treatment rate
  10. 13:46, 9 Nov 2025 (diff | hist) Missed dose 5,277 ±0 fix a dangling clause
  11. 23:13, 22 Oct 2025 (diff | hist) Reconstitution of lyophilised peptides 5,761 ±0 m rm the individualised advice — the article describes, it does not instruct
  12. 16:11, 2 Oct 2025 (diff | hist) Talk:Beyond-use date 1,022 +280 /* Date arithmetic: inclusive or exclusive? */ reply
  13. 19:46, 13 Jul 2025 (diff | hist) Multi-dose vial 18,051 +1,490 British spelling per PP:MOS
  14. 09:49, 12 Apr 2025 (diff | hist) Flourishglobal Peptide Biotech 5,367 +686 move a stray full stop inside the reference
  15. 08:44, 29 Mar 2025 (diff | hist) Talk:Multi-dose vial 1,033 +86 /* The 28-day rule is being cited as a stability figure */ reply
  16. 10:18, 27 Mar 2025 (diff | hist) Talk:Multi-dose vial 400 +302 /* The 28-day rule is being cited as a stability figure */ new section
  17. 03:34, 25 Feb 2025 (diff | hist) Patent expiry and biosimilars 3,173 +595 m add the date the shortage listing ended
  18. 15:29, 12 Feb 2025 (diff | hist) Test report forgery 3,991 +117 m add short description
  19. 02:55, 11 Feb 2025 (diff | hist) Cold chain 18,483 +506 m correct the humidity figure — relative humidity needs its temperature
  20. 02:16, 30 Jan 2025 (diff | hist) Bachem Holding (Suzhou) 7,241 +611 add the lead time for catalogue lines, as reported
  21. 19:11, 29 Jan 2025 (diff | hist) Bacteriostatic water 3,824 +247 state the number of doses a vial yields at that concentration
  22. 23:37, 25 Jan 2025 (diff | hist) Albumin binding half-life extension 4,511 +110 expand §Physical basis
  23. 04:57, 24 Dec 2024 (diff | hist) GLP-1 receptor agonist 8,122 ±0 m add CAS number, sourced
  24. 07:29, 4 Dec 2024 (diff | hist) Injection site rotation 2,929 ±0 m expand §Rotation schemes
  25. 17:01, 6 Nov 2024 (diff | hist) Prescribing information 2,473 ±0 correct the deductible description
  26. 12:01, 22 Oct 2024 (diff | hist) Dose escalation schedule 1,918 ±0 m add the diluent volume the example assumes
  27. 03:25, 17 Oct 2024 (diff | hist) Beyond-use date 3,225 +1,009 state that swirling rather than shaking is the handling convention, sourced
  28. 18:08, 14 Sep 2024 (diff | hist) Subcutaneous injection 2,928 +836 move a stray full stop inside the reference